- Home
- AEI vs MNOV Comparison
AEI vs MNOV Comparison
Compare AEI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEI | MNOV |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.4M | 76.5M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | AEI | MNOV |
|---|---|---|
| Price | $3.14 | $1.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 35.6K | ★ 141.7K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,108,028.00 | $257,917.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.70 | $1.13 |
| 52 Week High | $4.55 | $2.37 |
Technical Indicators
Market Signals| Indicator | AEI | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 59.61 |
| Support Level | $2.51 | $1.41 |
| Resistance Level | $3.33 | $1.63 |
| Average True Range (ATR) | 0.27 | 0.07 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 67.86 | 80.00 |
Price Performance
Historical ComparisonAbout AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.